JPH09510722A - 注射可能なジリスロマイシン溶液 - Google Patents

注射可能なジリスロマイシン溶液

Info

Publication number
JPH09510722A
JPH09510722A JP7524954A JP52495495A JPH09510722A JP H09510722 A JPH09510722 A JP H09510722A JP 7524954 A JP7524954 A JP 7524954A JP 52495495 A JP52495495 A JP 52495495A JP H09510722 A JPH09510722 A JP H09510722A
Authority
JP
Japan
Prior art keywords
injectable solution
injectable
dilithromycin
solution according
ethanol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP7524954A
Other languages
English (en)
Japanese (ja)
Inventor
シュテファン ライナー
ベルンハルト ハーセル
Original Assignee
ベーリンガー インゲルハイム フェトメディカ ゲゼルシャフト ミット ベシュレンクテル ハフツング
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ベーリンガー インゲルハイム フェトメディカ ゲゼルシャフト ミット ベシュレンクテル ハフツング filed Critical ベーリンガー インゲルハイム フェトメディカ ゲゼルシャフト ミット ベシュレンクテル ハフツング
Publication of JPH09510722A publication Critical patent/JPH09510722A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP7524954A 1994-03-26 1995-03-23 注射可能なジリスロマイシン溶液 Pending JPH09510722A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4410637.8 1994-03-26
DE4410637A DE4410637C1 (de) 1994-03-26 1994-03-26 Injizierbare Lösungen von Dirithromycin
PCT/EP1995/001096 WO1995026191A1 (fr) 1994-03-26 1995-03-23 Solutions injectables de dirithromycine

Publications (1)

Publication Number Publication Date
JPH09510722A true JPH09510722A (ja) 1997-10-28

Family

ID=6514000

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7524954A Pending JPH09510722A (ja) 1994-03-26 1995-03-23 注射可能なジリスロマイシン溶液

Country Status (7)

Country Link
EP (1) EP0754047A1 (fr)
JP (1) JPH09510722A (fr)
AU (1) AU2214195A (fr)
CO (1) CO4370014A1 (fr)
DE (1) DE4410637C1 (fr)
WO (1) WO1995026191A1 (fr)
ZA (1) ZA952405B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013537222A (ja) * 2010-09-16 2013-09-30 エルジー ライフ サイエンス リミテッド 保存効力を示す非水性油性注射用製剤

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19518917A1 (de) * 1995-05-23 1996-11-28 Boehringer Ingelheim Vetmed Stabile, konzentrierte lokalverträgliche Erythromycylamin-Lösungen
DE19701949A1 (de) * 1997-01-13 1998-07-16 Jenapharm Gmbh Transdermales therapeutisches System

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT342770B (de) * 1975-04-07 1978-04-25 Thomae Gmbh Dr K Verfahren zur herstellung neuer erythromycinderivate
DE3209429A1 (de) * 1982-03-16 1983-10-06 Boehringer Ingelheim Vetmed Mittel zur verbesserung der resorption von injizierten antibakteriell wirksamen substanzen und kombinationen, enthaltend ein benzyaminderivat
US4918108A (en) * 1982-03-16 1990-04-17 Boehringer Ingelheim Vetmedica Gmbh Method of improving the absorption of injected antibacterial substances
EP0473707A4 (en) * 1989-05-26 1992-12-09 Abbott Laboratories Injectable clarithromycin composition

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013537222A (ja) * 2010-09-16 2013-09-30 エルジー ライフ サイエンス リミテッド 保存効力を示す非水性油性注射用製剤

Also Published As

Publication number Publication date
EP0754047A1 (fr) 1997-01-22
ZA952405B (en) 1995-09-26
WO1995026191A1 (fr) 1995-10-05
CO4370014A1 (es) 1996-10-07
DE4410637C1 (de) 1995-09-21
AU2214195A (en) 1995-10-17

Similar Documents

Publication Publication Date Title
US5589455A (en) Cyclosporin-containing soft capsule compositions
EP0917457B1 (fr) Formes posologiques pharmaceutiques biphasees, a multiples composants, contenant des substances permettant de modifier la separation des medicaments
JP3391961B2 (ja) サイクロスポリン含有軟質カプセル剤組成物
US7182956B2 (en) Stable topical drug delivery compositions
DE69529060T2 (de) Verwendung eines lipophilen tensids in einer pharmazeutischen zusammensetzung
EP1578325B1 (fr) Compositions stables pour une administration de medicament topique
KR890700036A (ko) 비내 투여용 제제 및 그 제조방법
JP2963537B2 (ja) クラリトロマイシンの注射用組成物
CN101909664A (zh) 咪喹莫特制剂
US5747069A (en) Percutaneously absorbable preparation
WO2000035456A1 (fr) Systeme d'administration percutanee contenant de la buprenorphine
WO2002009764A1 (fr) Compositions combinees
JP2004051487A (ja) 経皮吸収製剤
JP2003503339A (ja) 抗癌剤を含有する自己乳化システム
CZ83598A3 (cs) Přípravek obsahující cyklosporin a způsob jeho přípravy
CN118304253A (zh) 一种缓释制剂组合物
WO1997021440A1 (fr) Solution contenant de l'ici 182,780 destinee a l'administration par voie orale
JPH09510722A (ja) 注射可能なジリスロマイシン溶液
JPH0413624A (ja) ピロキシカム含有局所投与用医薬組成物
KR100426346B1 (ko) 자가미세유화형 약물전달시스템을 이용한 고지혈증치료용약제 조성물
AU7155891A (en) Pharmaceutical formulation
JP2973077B2 (ja) ビタミンｅ製剤組成物
AU2004246961A1 (en) Transnasal microemulsions containing diazepam
JPH0371409B2 (fr)
WO1997004795A2 (fr) Compositions pharmaceutiques contenant de la cyclosporine et d'autres substances peptidiques